Clinical Trials Directory

Trials / Completed

CompletedNCT01538355

A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis

A Randomised Controlled Pilot Study to Compare the Effects of Prolonged Fasting and Ketogenic Low Glycemic Load Treatment on Health Related Quality of Life in Relapsing-remitting Multiple Sclerosis.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years – 68 Years
Healthy volunteers
Not accepted

Summary

It is well accepted that nutrition as an environmental factor is involved in the pathogenesis of multiple sclerosis. But is there a role for prolonged fasting and ketogenic low glycemic load treatment to alter the course of multiple sclerosis (MS)? The investigators think yes there is. Primarily the investigators want to detect if these diets are feasible for MS patients. Therefore the investigators examine the impact of this dietary intervention on the health related quality of life for individuals after 7 days, 3 months and 6 months in compare to baseline. Secondarily the investigators focus on endocrinological and immunological changes after 7 days, 3 months and 6 months in compare to baseline.

Detailed description

In this controlled randomised pilot study the patients are allocated to 1. a ketogenic low glycemic load treatment from the outset of the study for 24 weeks or 2. enhance their regular diet with an initial 7-day fasting followed by a Mediterranean diet pattern until the study end or 3. stay on their regular diet (control group) from the outset of the study for 24 weeks. The investigators will then assess the differences between the groups.

Conditions

Interventions

TypeNameDescription
OTHERProlonged FastingPatients enhance their regular diet with an initial 7-day fasting episode.
OTHERKetogenic low glycemic load treatment6 months of ketogenic low glycemic load treatment from the study outset.
OTHERControl dietPatients stay on their regular diet.

Timeline

Start date
2012-07-30
Primary completion
2013-02-28
Completion
2020-06-23
First posted
2012-02-24
Last updated
2021-04-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01538355. Inclusion in this directory is not an endorsement.